U.S. Wireless Telecom Stock News

Thermo Fisher Scientific product launches and what they mean for the stock Thermo Fisher Scientific (TMO) has just introduced the EMPAD G2 detector and new Orbitrap Isora mass spectrometers, two product launches that give investors fresh context for thinking about the stock and its role in advanced research tools. These launches arrive after a strong run for Thermo Fisher Scientific, with a 90-day share price return of 25.94% and a 1-year total shareholder return of 26.73%. Short-term...

AT&T stock has delivered a very strong 3 year return, yet current valuation checks still suggest the shares lean cheap on broader metrics rather than being priced for perfection. Over the past 3 years AT&T has returned 107.9%, which puts recent short term moves into a longer context of a strong rebound. The new partnership with Hark on AI native consumer devices can support expectations around future connectivity demand, while execution risk in turning such partnerships into durable cash...

General Motors stock has climbed 164.5% over the past three years, yet current checks send a split message, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to around 37.6% potential upside while market based multiples screen the shares as overvalued. A 164.5% gain over three years puts General Motors among the stronger movers in large cap autos, which can make fresh entry points and position sizing more sensitive to valuation assumptions. The build out of refreshed trucks...

Board change puts Levi Strauss stock in focus Levi Strauss (LEVI) drew investor attention after long serving director Robert Eckert retired from the board on August 14, 2026, in line with the company’s age based governance guidelines. Eckert had served since 2010 and previously chaired the board as well as the Nominating, Governance and Corporate Citizenship Committee. Joshua Prime now chairs that committee, and the board has been reduced to ten directors. Levi Strauss shares trade at...

Incyte stock has delivered a strong 92.3% gain over the past three years, yet current valuation checks suggest investors may be paying a premium to the intrinsic value estimate while traditional multiples look more in line with peers. The result is a stock that no longer looks obviously cheap, even after a solid multi year run. Incyte has returned 92.3% over three years, which puts more pressure on today’s valuation to be supported by future cash flows rather than past share price...

What Sonic Automotive’s latest expansion means for shareholders Recent acquisitions in luxury and powersports dealerships, together with fresh digital tools and locations in the EchoPark used-vehicle segment, are in focus for investors watching Sonic Automotive (SAH) after these expansion moves. The company is leaning more on fixed operations, premium brands, and powersports exposure. At the same time, EchoPark investments support used-car sales growth but also weigh on margins and keep...

Fox has delivered a strong 3 year share price gain, yet current valuation checks give a mixed message as the Discounted Cash Flow (DCF) estimate lines up close to the market price while earnings multiples still point to upside. Over the past 3 years, Fox has returned 127.6%, which puts recent enthusiasm in sharp focus for anyone thinking about new money going into the stock. Future cash generation from Fox's media assets can support the current price if margins and cash conversion hold up,...

War disruption in the Persian Gulf has added about $330b to global oil, fuel and LNG import costs between March and August, shaking energy markets and putting fresh focus on producers. That kind of shock can create sharp winners and losers, and investors who ignore it risk missing meaningful shifts in pricing power. This article breaks down three stocks from our Global Oil & Gas Producers screener that appear closely exposed to this news and explains what that might mean for your...

Septerna (SEPN) has drawn fresh investor attention after appointing Rajiv Patni, M.D., as Chief Medical Officer. The move raises new questions about how his track record in drug development could influence the company’s clinical priorities and risk profile. Septerna’s latest executive change comes after a strong run in the stock, with the share price at US$38.91 and a year to date share price return of 39.06%, alongside a very large 1 year total shareholder return of 221.57%. Spot momentum in...

Equifax Inc. previously declared a quarterly dividend of US$0.56 per share, paid on September 15, 2026, to shareholders of record as of August 31, 2026, extending a cash dividend track record that spans more than 100 consecutive years. The dividend affirmation, alongside recent legal developments and upcoming conference appearances, highlights how Equifax is balancing shareholder returns with ongoing regulatory and operational priorities. We’ll now examine how resolving a major legal...

Strive stock has surged over the past month, yet the broader valuation checks do not flag it as a clear bargain. This makes the recent strength harder to read for investors trying to anchor expectations. Strive has returned 95.7% over the past month, which puts the recent momentum well ahead of its longer term share price record. The key driver for valuation now is how reliably Strive can convert its business into durable cash flows. Any signs of weak profitability or a need for ongoing...

IDEX (IEX) stock activity in August has been shaped more by the company’s strong second quarter than by boardroom news. Investors are weighing record orders above US$1b, alongside a recent director resignation. Over the past year, IDEX’s share price has risen strongly, with a year to date share price return of 28.6% and a 1 year total shareholder return of 42.07%. This suggests momentum has been building as investors react more to the second quarter earnings beat and record US$1b plus order...

United Therapeutics (NasdaqGS: UTHR) plans to present late breaking analyses from several phase 3 studies at upcoming European scientific congresses. Key data sets include ADVANCE OUTCOMES for ralinepag in pulmonary arterial hypertension, TETON for nebulized treprostinil in idiopathic pulmonary fibrosis, and ARTISAN for parenteral treprostinil in pulmonary arterial hypertension. The company will also share preliminary findings from the PHINDER study, adding to the clinical evidence around...

Washington’s 100 year concessions over 17 Venezuelan oilfields have suddenly put long term oil supply politics back in the spotlight, and that ripples into refiners and fuel retailers you may already track. This deal could reshape how capital, contracts and risk are priced across the sector. This article walks through three stocks exposed to the news, and why this development could matter for your portfolio decisions. The stocks covered below are just a sample, and the full screen surfaced 27...

Gorman-Rupp (GRC) has outlined a new growth plan centered on organic expansion, renewed interest in acquisitions, and continued debt reduction. Management is highlighting opportunities in data centers, water infrastructure, and international markets. Gorman-Rupp’s recent growth update comes after a mixed stretch for the stock, with the share price down 6.12% over the past month, up 3.41% over 90 days, and showing a 58.33% year to date share price return. The 1-year total shareholder return of...

With Fed chair Kevin Warsh signaling a tougher stance on inflation and markets bracing for higher-for-longer rates, interest rate sensitive stocks are back in focus. This shift creates potential winners and losers as funding costs and lending income reshuffle across the market. This article walks through three U.S. regional and national bank stocks exposed to this new rate story and explains how the latest policy message could affect each one. The stocks in this article are just a starter...

In recent weeks, Sports Research announced the rollout of its new creatine capsules and upcoming Creatine + Electrolytes line at Costco, while Costco and Instacart enabled nationwide online ordering and delivery of custom cakes and party platters through Instacart and sameday.costco.com. Together, these moves highlight Costco’s effort to broaden its wellness assortment and deepen digital convenience as in-warehouse traffic growth moderates. Next, we’ll examine how Costco’s new...

Space Exploration Technologies (SPCX) has become a focal point for investors after completing the largest US IPO in June, alongside an ambitious US$100b Starbase Louisiana project and a rapidly expanding AI segment. The recent news flow around Space Exploration Technologies, from the record US IPO to the US$100b Starbase Louisiana plan and rapid AI build out, has arrived alongside a sharp shift in market sentiment. The stock has a 30 day share price return of 30.57% and a 7 day share price...

Target (NYSE:TGT) has launched a new in store and online partnership with fast growing hydration brand k2o, which has already sold significant volumes and generated meaningful sales in its first weeks. The k2o rollout expands Target's wellness and hydration assortment and may appeal to new, more engaged customer segments. Target has also filed two large shelf registrations, including an ESOP related equity shelf and a broad omnibus shelf covering multiple types of securities. The filings...

Vistance Networks has seen its share price fall sharply in recent weeks after a very large three year gain, while several valuation checks still indicate the stock screens as cheap relative to an estimate of intrinsic value. The question for investors is whether that recent drop simply brought the price closer to fair value or whether the market is now pricing Vistance Networks below what its future cash flows may support. Over the past three years, Vistance Networks has returned a very...

Olin stock has been under clear pressure in recent years, yet the valuation checks currently lean cheap relative to the broader market. With the share price weak and sentiment tested by operational issues and legal scrutiny, investors are weighing whether the current level already reflects those concerns. Olin has fallen about 64.1% over the past 3 years, which puts the stock firmly in a recovery camp rather than a recent winner. The planned all stock merger with Huntsman can reshape the...

Unum Group buyback announcement and why it matters for shareholders Unum Group (UNM) has announced a new share repurchase program, with Board approval on 26 August 2026 to buy back up to US$1.0b of its outstanding common stock. This authorization gives Unum Group flexibility to return additional capital to shareholders over time. Investors often watch such buyback plans closely because they can affect earnings per share and the stock’s supply in the market. Unum Group’s buyback news arrives...

Carnival stock has delivered a strong 59.9% gain over the past three years, yet the current share price and the broader checks still point to a company that screens cheaply on several fronts. For investors, the question is why a stock with that track record and a high value score has not rerated more convincingly. Over the past three years, Carnival has returned 59.9%, which shows the stock has already rewarded investors who stayed through a difficult period. Future demand for cruises and...

Earlier this quarter, IQVIA Holdings reported past second-quarter results that exceeded earnings expectations, with adjusted earnings rising 12.1% year over year and revenue up 8.7%, prompting management to raise its 2026 revenue, adjusted EBITDA and adjusted diluted earnings guidance. The upgraded guidance, backed by broad-based demand, strong bookings and contributions from acquisitions, is reshaping how investors view IQVIA’s ability to sustain its business momentum into 2027. We’ll now...